Author: Erik R. Giannitrapani

Amniotic Allograft Fraud: Is It Legitimate Wound Care or Expensive Snake Oil?

Takeaway: Wound care fraud is now one of the key enforcement priorities of the Department of Justice. An aging population, combined with Medicare’s pricing policies, nurtured an opportunity for Amniotic Allograft Fraud to explode.

Approximately 8.8 million Americans suffer from chronic wounds (wounds that are present for four weeks or more without signs of healing),

Will Whistleblowers Opportunities Rise If/When the Special Inspector General for Pandemic Recovery “Sunsets?”

Without Congressional action, the authority of the Special Inspector General for Pandemic Recovery (SIGPR) will sunset on March 27, 2025. The Coronavirus Aid, Relief, and Economic Security (CARES) Act was enacted in March 2020 to provide emergency financial assistance to millions of Americans suffering the economic effects of the COVID-19 pandemic.

6th Circuit Draws a Bright Line Between Regulatory Non-Compliance and Fraudulent Inducement in a Defense Contracting Case

Takeaway: 6th Circuit provided a path forward for a common defense contracting fraud allegation.

In United States ex rel. USN4U, LLC v. Wolf Creek Federal Services[1] the 6th Circuit overturned the lower courts dismissal of a qui tam complaint that alleged a NASA contractor knowingly inflated the prices of its labor costs in Cost Estimates for fixed price contracts.

The Third Circuit Rules that the FCA’s “Alternate-Remedy Provision” Does Not Provide a Relator the Right to Intervene in a Criminal Proceeding for a Piece of the Criminal Restitution

On October 28, 2019, the Third Circuit became the most
recent circuit court to determine that the False Claims Act’s (“FCA”) other
alternate-remedy provision, 31 U.S.C. § 3730(c)(5), does not give a relator the
right to intervene in a criminal proceeding. United States v. Wegeler, 2019 WL 5538568,

Contact one of our

Experienced Attorneys

If you are aware of any person, corporation or entity that you think may be violating the False Claims Act, securities, commodities, tax, anti-money laundering, or sanctions laws, contact us today.

CONTACT US